These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 30885850)

  • 21. Multigene mutation analysis of metastatic lymph nodes in non-small cell lung cancer diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration.
    Nakajima T; Yasufuku K; Nakagawara A; Kimura H; Yoshino I
    Chest; 2011 Nov; 140(5):1319-1324. PubMed ID: 21527506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adequacy of endobronchial ultrasound transbronchial needle aspiration samples in the subtyping of non-small cell lung cancer.
    Esterbrook G; Anathhanam S; Plant PK
    Lung Cancer; 2013 Apr; 80(1):30-4. PubMed ID: 23312886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Performance of an Extended Next Generation Sequencing Panel Using Endobronchial Ultrasound-Guided Fine Needle Aspiration Samples in Non-Squamous Non-Small Cell Lung Cancer: A Pragmatic Study.
    Zhang C; Kim RY; McGrath CM; Andronov M; Haas AR; Ma KC; Lanfranco AR; Hutchinson CT; Morrissette JJD; DiBardino DM
    Clin Lung Cancer; 2023 Mar; 24(2):e105-e112. PubMed ID: 36599742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal Growth Factor Receptor (EGFR) Mutations and Anaplastic Lymphoma Kinase/Oncogene or C-Ros Oncogene 1 (ALK/ROS1) Fusions Inflict Non-Small Cell Lung Cancer (NSCLC) Female Patients Older Than 60 Years of Age.
    Ke L; Xu M; Jiang X; Sun X
    Med Sci Monit; 2018 Dec; 24():9364-9369. PubMed ID: 30580372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective Clinical Integration of an Amplicon-Based Next-Generation Sequencing Method to Select Advanced Non-Small-Cell Lung Cancer Patients for Genotype-Tailored Treatments.
    Zugazagoitia J; Rueda D; Carrizo N; Enguita AB; Gómez-Sánchez D; Díaz-Serrano A; Jiménez E; Mérida A; Calero R; Lujan R; De Miguel E; Gámez P; Díaz-Hellín V; Nuñez JA; Iglesias L; Ferrer I; Paz-Ares L; Ponce-Aix S
    Clin Lung Cancer; 2018 Jan; 19(1):65-73.e7. PubMed ID: 28780976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non-small-cell Lung Cancer: Implications of FISH-positive Patterns.
    Clavé S; Rodon N; Pijuan L; Díaz O; Lorenzo M; Rocha P; Taus Á; Blanco R; Bosch-Barrera J; Reguart N; de la Torre N; Oliveras G; Espinet B; Bellosillo B; Puig X; Arriola E; Salido M
    Clin Lung Cancer; 2019 Jul; 20(4):e421-e429. PubMed ID: 30898567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of adequacy between transbronchial lung cryobiopsy samples and endobronchial ultrasound-guided transbronchial needle aspiration samples for next-generation sequencing analysis.
    Tone M; Inomata M; Awano N; Kuse N; Takada K; Minami J; Muto Y; Fujimoto K; Kumasaka T; Izumo T
    Thorac Cancer; 2021 Jan; 12(2):251-258. PubMed ID: 33270369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective.
    Aggarwal A; Sharma S; Brar Z; Kumar V; Kumar A; Katara R; Mohanty SK
    Pathol Res Pract; 2024 Jan; 253():155013. PubMed ID: 38096714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of lung cancer biomarkers profile for the decision of targeted therapy in EBUS-TBNA cytological samples.
    Gürün Kaya A; Çiledağ A; Erol S; Öz M; Doğan Mülazımoğlu D; Işık Ö; Özakıncı H; Çiftçi F; Şen E; Ceyhan K; Kaya A; Karnak D; Çelik G; İsmail S
    Scott Med J; 2022 Feb; 67(1):18-27. PubMed ID: 35147461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the slow-pull and aspiration methods of endobronchial ultrasound-guided transbronchial needle aspiration for next-generation sequencing-compatible tissue collection in non-small cell lung cancer.
    Kajita Y; Teranishi S; Sawazumi T; Watanabe H; Nagaoka S; Tanaka A; Suzukawa Y; Motobayashi Y; Hirose T; Maeda C; Seki K; Tashiro K; Kobayashi N; Yamamoto M; Kudo M; Inayama Y; Kaneko T
    Cancer Med; 2023 Oct; 12(19):19512-19522. PubMed ID: 37732488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Testing for Targeted Therapy in Advanced Non-Small Cell Lung Cancer: Suitability of Endobronchial Ultrasound Transbronchial Needle Aspiration.
    Casadio C; Guarize J; Donghi S; Di Tonno C; Fumagalli C; Vacirca D; Dell'Orto P; De Marinis F; Spaggiari L; Viale G; Barberis M
    Am J Clin Pathol; 2015 Oct; 144(4):629-34. PubMed ID: 26386084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing a New qPCR-Based System for Screening Mutation.
    Zhu J; Zhao Y; Liu M; Gonzalez-Rivas D; Xu X; Cai W; Qi H; Dai L; Wang Z; Song X; Jiang G; Yang Y
    Small; 2019 Mar; 15(9):e1805285. PubMed ID: 30677225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Next-generation sequencing of liquid-based cytology non-small cell lung cancer samples.
    Reynolds JP; Zhou Y; Jakubowski MA; Wang Z; Brainard JA; Klein RD; Farver CF; Almeida FA; Cheng YW
    Cancer Cytopathol; 2017 Mar; 125(3):178-187. PubMed ID: 28085233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EML4-ALK fusion gene assessment using metastatic lymph node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration.
    Sakairi Y; Nakajima T; Yasufuku K; Ikebe D; Kageyama H; Soda M; Takeuchi K; Itami M; Iizasa T; Yoshino I; Mano H; Kimura H
    Clin Cancer Res; 2010 Oct; 16(20):4938-45. PubMed ID: 20926401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Testing in EBUS-TBNA Specimens of Lung Adenocarcinoma: A Study of Concordance Between Cell Block Method and Liquid-Based Cytology in Appraising Sample Cellularity and EGFR Mutations.
    Magnini D; Fuso L; Varone F; D'Argento E; Martini M; Pecoriello A; Di Noia V; Arciuolo D; Fadda G; Rindi G; Richeldi L
    Mol Diagn Ther; 2018 Dec; 22(6):723-728. PubMed ID: 30276554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance Mechanisms to Targeted Therapies in
    McCoach CE; Le AT; Gowan K; Jones K; Schubert L; Doak A; Estrada-Bernal A; Davies KD; Merrick DT; Bunn PA; Purcell WT; Dziadziuszko R; Varella-Garcia M; Aisner DL; Camidge DR; Doebele RC
    Clin Cancer Res; 2018 Jul; 24(14):3334-3347. PubMed ID: 29636358
    [No Abstract]   [Full Text] [Related]  

  • 37. Feasibility of endobronchial ultrasound transbronchial needle aspiration for massively parallel next-generation sequencing in thoracic cancer patients.
    Turner SR; Buonocore D; Desmeules P; Rekhtman N; Dogan S; Lin O; Arcila ME; Jones DR; Huang J
    Lung Cancer; 2018 May; 119():85-90. PubMed ID: 29656758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration With and Without Rapid On-site Evaluation for Lung Cancer Genotyping.
    Trisolini R; Cancellieri A; Tinelli C; de Biase D; Valentini I; Casadei G; Paioli D; Ferrari F; Gordini G; Patelli M; Tallini G
    Chest; 2015 Dec; 148(6):1430-1437. PubMed ID: 26158441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protocol to Improve Genotyping of Non-Small-Cell Lung Cancer Diagnosed Using EBUS-TBNA.
    Bellinger CR; Sharma D; Dotson T; Ruiz J; Parks G; Haponik EF
    South Med J; 2018 Oct; 111(10):601-606. PubMed ID: 30285266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapy.
    Faber E; Grosu H; Sabir S; San Lucas FA; Barkoh BA; Bassett RL; Luthra R; Stewart J; Roy-Chowdhuri S
    J Clin Pathol; 2022 Sep; 75(9):612-619. PubMed ID: 33952592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.